Clinics and Departments

Laboratory Services

Lab Dept:


Test Name:


General Information

Lab Order Codes:



HIV Monitor Test, RT-PCR; HIV-1 PCR; HIV-1 Quantitation, PCR; HIV-1 RNA, Viral Load; Human Immunodeficiency Virus, PCR; PCR, HIV-1 Quantitation; Quantitation, HIV Monitor Test RT-PCR; Viral Load, HIV-1 RNA; HIV-1 Quantitation Ultra Sensitive

CPT Codes:

87536 – HIV-1, quantification

Test Includes:

Detection of HIV-1 RNA either as undetected or reported in copies/mL.


Test Indications:

Quantifying plasma HIV-1 RNA levels (viral load) in HIV-1 infected patients before initiating anti-HIV-1 drug therapy (baseline viral load), those who may have developed HIV-1 drug resistance while on therapy, or those who are non-compliant with anti-HIV-1 drug therapy. Indirect monitoring for evidence of HIV-1 resistance during anti-HIV-1 drug therapy. Monitoring HIV-1 disease progression while on or off anti-HIV-s drug therapy. Evaluating infants <18 months of age born to HIV-infected mothers.

This test is intended to be used to monitor known HIV-positive infections. It is not intended for primary detection of HIV infections except in children <18 months of age.

Lab Testing Sections:

Microbiology/Virology - Sendouts

Referred to:

Mayo Medical Laboratories (MML Test: 81958/HIVQU)

Phone Numbers:

MIN Lab: 612-813-6280

STP Lab: 651-220-6550

Test Availability:

Daily, 24 hours

Turnaround Time:

1 – 3 days, test set up Monday - Saturday

Special Instructions:

Specimen must be centrifuged and plasma removed within 6 hours of collection.


Specimen Type:



Lavender top (EDTA) tube

Draw Volume:

7.5 mL blood

Processed Volume:

2.5 mL plasma


Routine venipuncture

Special Processing:

Lab Staff: Processing must occur within 6 hours of collection. Aseptically centrifuge the specimen, remove plasma aliquot and place in a screw-capped plastic vial. Freeze immediately. Store and ship at frozen temperatures. Avoid specimen to specimen contamination, freeze-thaw cycles, prolonged ambient exposure. Forward promptly.

Patient Preparation:


Sample Rejection:

Avoid freeze/thaw cycles; prolonged ambient temperature exposure; obvious microbial contamination; specimen to specimen contamination; incorrect anticoagulant, mislabeled or unlabeled specimens; specimens other than EDTA


Reference Range:


If detected, results are reported in copies/mL.

Interpretation: This assay has a plasma HIV-1 RNA quantification result range from 20 copies/mL to 10,000,000 copies/mL.

An “undetected” result indicates that the assay was unable to detect HIV-1 RNA with the plasma specimen.

A “detected” result with the comment, “HIV-1 RNA detected, but <20 HIV-1 copies/mL”, indicates that HIV-1 RNA is detected, but the level present is less than the lower quantification limit of the assay. Possible causes of such a result include very low plasma HIV-1 viral load present (eg, in the range of 1-19 copies/mL), very early early HIV-1 infection (ie, <3 weeks from time of infection), or absence of HIV-1 infection (ie, imprecision of the assay).

A “detected” result with the comment, “Greater than 10,000,000 HIV-1 RNA copies/mL”, indicates that HIV-1 RNA is detected, but the level present is above the upper quantification limit of this assay.

Critical Values:



This test is not licensed by the Food and Drug Administration (FDA) as a screening test for HIV-1 infections in a post-exposure setting. Although this quantitative HIV-1 RNA test is not FDA approved for diagnostic purposes, the US Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children does recommend use of proviral DNA and RNA for the detection of HIV infection in infants of <18 months of age and born to HIV-infected mothers.

A single HIV-1 viral load test result should not be used as the only criteria to guide therapeutic decision and intervention in the clinical care of HIV-1-infected patients. Viral load results should be correlated with patient symptoms, clinical presentation, and CD4 cell count. Due to the inherent variability in the assay, physiologic variation and concurrent illnesses in the infected patients, <100-fold (<2 log) change in plasma HIV-1 viral load should not be considered as significant change.

Viral load results of <20 copies/mL do not necessarily indicate absence of HIV-1 viral replication. Inhibitory substances may be present in the plasma specimen, leading to negative or falsely low HIV-1 RNA results. Improper specimen collection or storage may falsely lower the plasma viral load results.

This commercial viral load assay is optimized only for quantification of plasma viral load in HIV-1 infection due to HIV-1 group M, subtypes A to H and groups N and O. The assay is not reliable for quantifying plasma viral loads in infection caused by HIV-2 strains.

Plasma specimens collected using ACD anticoagulant show quantitative HIV-1 RNA levels that are ~15% lower than those collected in tubes containing EDTA.


Reverse Transcription-Polymerase Chain Reaction (RT-PCR)

PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.


Mayo Medical Laboratory August 2013


4/21/2004: Test moved from Fairview University Diagnostic Laboratories forward to ARUP to Mayo Medical Laboratories.
8/10/2004: Ultra Sensitive was added to the test name.
8/19/2008: Ultra Sensitive removed from test name as per Mayo.
7/14/2009: Minimum volume of 1.2 mL plasma removed due to short sampling/QNS specimens. Instrument change at Mayo (COBAS AmpliPrep/COBAS TaqMan HIV-1)
5/4/2010: Minimum volume of 1.2 mL plasma reinstated.
1/3/2011: Minimum volume removed due to test cancellations.

  Lab Test Directory
    Microbiology/ Virology
    Other Fluids
    Transfusion Services

  Search Lab Test Directory
    List All Documents

  Lab Staff

  E-mail Lab Services